Brain

Neuropathy No More Under Review: Blue Heron Health News’ Nerve Pain Relief Tips GuideNeuropathy No More Under Review: Blue Heron Health News’ Nerve Pain Relief Tips Guide

Neuropathy No More Under Review: Blue Heron Health News’ Nerve Pain Relief Tips Guide

Natural Nerve Pain Relief Guide by Jodi Knapp Offers Holistic, Non-Pharmaceutical Approach to Peripheral Neuropathy—Emphasizing Gut Health, Lifestyle Changes, and…

2 weeks ago
Eastern Michigan University unveils Way Forward@EMU, empowering youth health leaders with $1M Toyota grantEastern Michigan University unveils Way Forward@EMU, empowering youth health leaders with $1M Toyota grant

Eastern Michigan University unveils Way Forward@EMU, empowering youth health leaders with $1M Toyota grant

YPSILANTI, Mich., May 16, 2025 /PRNewswire/ -- Eastern Michigan University is revolutionizing health education for young leaders with the launch…

2 weeks ago
Brainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer IngelheimBrainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer Ingelheim

Brainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer Ingelheim

New studies presented at the American Thoracic Society (ATS) Conference this week validate e-Lung as an accurate tool to identify…

2 weeks ago
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare ConferenceHyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared…

2 weeks ago
BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate UpdateBrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW YORK, May 15, 2025 /PRNewswire/…

2 weeks ago
ALS NETWORK ANNOUNCES RESEARCH FUNDS AWARDED TO LIVERMORE LAB FOUNDATIONALS NETWORK ANNOUNCES RESEARCH FUNDS AWARDED TO LIVERMORE LAB FOUNDATION

ALS NETWORK ANNOUNCES RESEARCH FUNDS AWARDED TO LIVERMORE LAB FOUNDATION

Researchers to Analyze Medication Effects on Development and Progression of ALS and Parkinson's Diseases LOS ANGELES, May 15, 2025 /PRNewswire/…

2 weeks ago
GrayMatters Health Expands Mental Health Solutions Portfolio with Launch of Prism™ SuiteGrayMatters Health Expands Mental Health Solutions Portfolio with Launch of Prism™ Suite

GrayMatters Health Expands Mental Health Solutions Portfolio with Launch of Prism™ Suite

Innovative Prism™ Platform Now Includes Protocol for Patients with Depression  NEW YORK, May 15, 2025 /PRNewswire/ -- GrayMatters Health (GMH),…

2 weeks ago
Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau AssaysAlamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research FREMONT, Calif., May 15,…

2 weeks ago
Stimvia Graduates from NYU Stern’s Elite Accelerator, Targets U.S. Market with Breakthrough Bladder TherapyStimvia Graduates from NYU Stern’s Elite Accelerator, Targets U.S. Market with Breakthrough Bladder Therapy

Stimvia Graduates from NYU Stern’s Elite Accelerator, Targets U.S. Market with Breakthrough Bladder Therapy

NEW YORK and PRAGUE, May 14, 2025 /PRNewswire/ -- Stimvia, a medtech company from the Czech Republic developing a non-invasive…

3 weeks ago